Related references
Note: Only part of the references are listed.Docosapentaenoic acid monoacylglyceride reduces inflammation and vascular remodeling in experimental pulmonary hypertension
Caroline Morin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Inhibitory Role of PIP2 on Calcium-Activated Chloride Channel Activity
Harry A. T. Pritchard et al.
BIOPHYSICAL JOURNAL (2014)
Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32
Hye Ja Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cells
Caroline Morin et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2013)
Resolvins as New Fascinating Drug Candidates for Inflammatory Diseases
Chang Hoon Lee
ARCHIVES OF PHARMACAL RESEARCH (2012)
Inflammation in Pulmonary Arterial Hypertension
Laura C. Price et al.
CHEST (2012)
TMEM16A/ANO1 Channels Contribute to the Myogenic Response in Cerebral Arteries
Simon Bulley et al.
CIRCULATION RESEARCH (2012)
Novel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
Charles N. Serhan et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
The anoctamin (TMEM16) gene family: calcium-activated chloride channels come of age
John P. Winpenny et al.
EXPERIMENTAL PHYSIOLOGY (2012)
Resolvin D1 and Resolvin D2 Govern Local Inflammatory Tone in Obese Fat
Joan Claria et al.
JOURNAL OF IMMUNOLOGY (2012)
Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
Alexandre P. Rogerio et al.
JOURNAL OF IMMUNOLOGY (2012)
Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation
Xinli Qu et al.
JOURNAL OF PATHOLOGY (2012)
Determination of PKC isoform-specific protein expression in pulmonary arteries of rats with chronic hypoxia-induced pulmonary hypertension
Yiwei Shi et al.
MEDICAL SCIENCE MONITOR (2012)
Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life
Danielle Swanson et al.
ADVANCES IN NUTRITION (2012)
19,20-EpDPE, a bioactive CYP450 metabolite of DHA monoacyglyceride, decreases Ca2+ sensitivity in human pulmonary arteries
Caroline Morin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
Gabrielle Fredman et al.
BIOCHEMICAL JOURNAL (2011)
Role for miR-204 in human pulmonary arterial hypertension
Audrey Courboulin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Omega-3 Fatty Acids and Cardiovascular Disease Effects on Risk Factors, Molecular Pathways, and Clinical Events
Dariush Mozaffarian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
17,18-Epoxyeicosatetraenoic Acid Targets PPARγ and p38 Mitogen-Activated Protein Kinase to Mediate Its Anti-inflammatory Effects in the Lung
Caroline Morin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Novel Lipid Mediators Promote Resolution of Acute Inflammation Impact of Aspirin and Statins
Matthew Spite et al.
CIRCULATION RESEARCH (2010)
Arachidonic Acid-metabolizing Cytochrome P450 Enzymes Are Targets of ω-3 Fatty Acids
Cosima Arnold et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions
Zhen-Zhong Xu et al.
NATURE MEDICINE (2010)
Emerging therapies for the treatment of pulmonary hypertension
Kurt R. Stenmark et al.
PEDIATRIC CRITICAL CARE MEDICINE (2010)
Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung
Caroline Morin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Resolvins and protectins: mediating solutions to inflammation
Payal Kohli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Signalling pathways involved in the contractile response to 5-HT in the human pulmonary artery
L. Rodat-Despoix et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
The new definition of pulmonary hypertension
M. M. Hoeper
EUROPEAN RESPIRATORY JOURNAL (2009)
Effects of ω-hydroxylase product on distal human pulmonary arteries
Caroline Morin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
EET displays anti-inflammatory effects in TNF-α-stimulated human bronchi
Caroline Morin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation
Oliver Haworth et al.
NATURE IMMUNOLOGY (2008)
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Charles N. Serhan et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries
C Guibert et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
The endothelin system in pulmonary arterial hypertension
N Galié et al.
CARDIOVASCULAR RESEARCH (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Right ventricular hypertrophy and apoptosis after pulmonary artery banding: regulation of PKC isozymes
MU Braun et al.
CARDIOVASCULAR RESEARCH (2003)
Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials
JM Geleijnse et al.
JOURNAL OF HYPERTENSION (2002)
Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility
T Kitazawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Endothelin and pulmonary hypertension
YF Chen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2000)
Share Paper
